Australia · Medical and donor conditions

Neutral fertility-consultation office with blank papers and a microscope behind glass

Australia surrogacy: medical screening and donor-gamete rules

The practical answer: identify the governing rule

Australia has no single nationwide medical certificate or donor checklist that automatically permits surrogacy. Start with the state or territory governing the proposed arrangement and treatment, then examine the law regulating surrogacy, the separate rules for assisted reproductive technology (ART), the national NHMRC ethical guidelines, and the clinic’s individual assessment. Being suitable for IVF is not the same as satisfying surrogacy conditions; donor availability is not proof that donor use is lawful. This guide concerns clinical and gamete requirements, not a complete test of residency, intended-parent status, contracts, birth registration or parentage.

National ART ethics and the treatment decision

The NHMRC ART Guidelines (2017, updated 2023) are professional ethical standards incorporated into clinic accreditation expectations, not a single substitute for every state statute. Their surrogacy chapter requires clinics to assess medical and psychological suitability, perform a single embryo transfer, provide counselling before, during and after treatment, obtain valid consent for each procedure, and check that a legal altruistic arrangement exists before ART proceeds. The surrogate retains authority over decisions concerning her own medical care. These duties do not mean that any particular laboratory result guarantees acceptance or that a clinic can waive a statutory prohibition.

How to separate rules from clinic policies

Decision layerWhat it decides / Your next check
State / territory lawBinding state or territory law may determine who may participate, the form of surrogacy available and whether approval is required before treatment. Ask a specialist lawyer to identify the actual provision and commencement date rather than relying on an interstate summary.
NHMRC and accreditationNHMRC ethical and accreditation expectations govern counselling, donor information, consent and safer ART practice. Ask the provider how compliance is documented, which guideline clauses it applies and whether any specific local statute imposes a stricter requirement.
Clinic assessmentClinical assessment and written clinic policy may address infectious-disease testing, pregnancy history, obstetric risks, mental-health assessment, gamete quality and treatment limits. Request the clinic’s precise test list, medical rationale, cost and reconsideration route; do not describe each preference as a national legal ban.
Agreement and paymentsA surrogacy agreement and proposed payments are a different question from medical suitability. An arrangement may be medically feasible but unable to proceed without required legal advice, consent, approvals or compliance with the prohibition on commercial surrogacy.

Donated sperm, eggs and embryos

When donor sperm, eggs or embryos are used, the clinic must address informed consent, donor medical and genetic history, infection-control screening, identity and record-keeping duties, and jurisdiction-specific limits. NHMRC guideline 5.6.1 says clinics must not use donated gametes in reproductive procedures unless the donor has consented to release identifying information to a person born from the donation. This is a national ethical/accreditation standard, not a single nationwide statute; state or territory law may add register and disclosure rules. There is a narrow legacy qualification: guideline 5.13 says gametes collected before the 2004 edition may be considered without that consent only in specified cases, including where the recipient already had a child using the same donor before that edition, or embryos made with those gametes were stored before then and the donor cannot be contacted. In either case, recipients must receive detailed information and be offered further counselling. Do not assume this exception applies without the clinic’s written basis and confirmation of local law. Permanent anonymity should not be promised for new clinic treatment. Chapter 6 adds protections for donated embryos. Consent to donation, embryo creation, storage, surrogacy treatment and future disclosure are separate questions.

Imported or previously stored gametes demand an extra documentary check: the origin and traceability of every provider, donor consents, screening and quarantine records, transport and storage history, relevant family-use limits, and any approval to receive or use the material. These controls may block treatment even if a donor bank overseas released the material. The treating Australian licensed or registered provider should confirm acceptance in writing before shipping or purchasing gametes; an overseas bank’s assurance cannot replace Australian compliance.

Victoria: a surrogate’s eggs and clinical approval

Victoria is an important example of a legal restriction that is not merely a clinic preference. VARTA explains that a surrogate treated at a registered Victorian fertility clinic must be at least 25, have previously given birth to a live child and must not use her own eggs in that clinic surrogacy procedure. Accordingly, Victorian clinics practise gestational rather than traditional surrogacy. VARTA also describes home insemination traditional surrogacy as possible outside a registered clinic, but this does not make the legal or parentage consequences equivalent. The commonly expressed preferred surrogate age band of 25–40 is guidance, not itself the statutory upper-age prohibition.

For treatment in Victoria, the Assisted Reproductive Treatment Act 2008 and official guidance set threshold conditions for clinic-based gestational surrogacy: the surrogate must be at least 25, must previously have given birth to a live child, and her own egg cannot be used. The Patient Review Panel (PRP) must approve the arrangement before a registered clinic carries out treatment. Intended parents must meet the medical eligibility criteria, including infertility or inability to conceive, carry or give birth, or a likely medical risk to the intended mother or child if she attempts pregnancy. Available official PRP guidance and application materials describe counselling and legal advice as required and request evidence of independent legal advice for the intended parents and surrogate (and her partner where relevant). VARTA’s public page is inconsistent on whether separate advice is formally required, so confirm the current documentation with the PRP; separate lawyers are prudent to avoid conflicts. Where donor material is used, check whether donors and partners must be included in the application and provide the required consent and record documents. A diagnosis, unsuccessful IVF history or stated risk does not automatically satisfy the statutory test; obtain a case-specific clinical opinion and current PRP instructions before embryo creation or transfer.

Western Australia: eligibility and imported donations

In Western Australia, current official guidance under the Surrogacy Act 2008 describes Reproductive Technology Council approval, a surrogate aged at least 25 and a previous child, subject to an exceptional-circumstances qualification regarding that child. Participants undergo counselling, medical and psychological suitability assessment and independent legal advice; donor participants can require additional steps. Access criteria for intended parents remain particularly restrictive and must be checked against their circumstances. A major 2025 reform Act received assent in December 2025, but WA Health states that the existing surrogacy and ART framework continues until the new Act commences, expected in mid-2027. Do not apply the announced reforms as operative 2026 law.

WA Health also states that imported donor material must satisfy counselling equivalence, screening and infection control, consent, family limits and register-information requirements, with evidence that the donor or broker received no prohibited financial benefit. A provider may seek Reproductive Technology Council relief in exceptional compassionate circumstances for a five-family limit or register information; WA Health does not describe a general waiver of all other import requirements. The receiving licensee carries responsibility. Applicants should obtain a written admissibility decision before transport, particularly where donations originated outside Australia.

New South Wales and Queensland

In New South Wales, registered ART providers must keep donor records, comply with consent and infection-control rules, and report donor and birth particulars to the Central Register. Donor-conceived people can access specified identifying information from age 18 under the applicable provisions. Section 27 generally prevents treatment if a donor’s gametes are likely to result in offspring born to more than five women across NSW and elsewhere, including overseas, or a lower number set by the donor. The statutory count can include women who conceived naturally or through ART and the donor’s current or former spouse where relevant. This is not an absolute rule: a family-completion exception applies where the woman or her spouse is already a parent of a child conceived using the same donor. A separate class exemption, in force from 17 October 2025, covers certain women who before 1 October 2025 had qualifying embryos or gametes stored or reserved, including some donor material held outside NSW where preliminary treatment began after 1 July 2025. It does not generally permit future treatment using newly selected, unreserved material. Transitional rules also exist for some pre-2010 material. Ask the clinic to identify the exact exception and dated records relied on. Where donor material is used in surrogacy, the provider must report the relevant particulars. Donor rules remain separate from the conditions for a surrogacy parentage order.

Queensland illustrates why a parentage-order test must not be confused with a clinic’s treatment criteria. Section 14 of the Surrogacy Act 2010 frames medical or social need for a parentage-order application by intended-parent circumstances: a sole intended parent who is a man or an “eligible woman”, or two intended parents who are a man and an eligible woman, two men, or two eligible women. The accessible official consolidated text identifies itself as current as at 24 June 2024 and defines an eligible woman through specified criteria, including inability to conceive, medical inability or risk associated with carrying or giving birth, or certain genetic or serious health risks to a child. This is not a nationwide rule requiring every intended parent to prove infertility, and a parentage-order test is not a complete clinical eligibility decision. Before relying on these categories, confirm the applicable text and required evidence with the legislation portal or a Queensland surrogacy specialist. Queensland’s Assisted Reproductive Technology Act 2024 is being implemented in stages. Queensland Health says provider licensing and enhanced informed-consent and counselling requirements commenced on 1 March 2026; stage 3 donor-conception register rollout is described as running throughout 2026. Confirm the register’s current operational status, the treatment date and any transitional or exemption process with Queensland Health and the provider.

Medical refusal, documents and sequence

Before paying or starting a treatment cycle, assemble a written decision pack: (1) state or territory of treatment and intended residence; (2) medical reports addressing the surrogate’s obstetric and psychological suitability and the intended parents’ eligibility, as required; (3) donor, gamete and embryo provenance, donor identity, infection and genetic screening, storage and transport records, and any family-limit or register information; (4) signed procedure-specific consents and permission for identity disclosure where required; (5) counselling and legal-advice evidence for relevant parties; (6) PRP, Council or other pre-treatment approvals and the clinic’s written policy; and (7) if relying on a statutory or legacy exception, the exact provision plus dated evidence showing that every condition is met. Ask the provider which items arise from legislation, NHMRC/accreditation standards or discretionary clinic policy, and which facts could trigger refusal. Share sensitive records through a secure clinical channel.

A safe order is to select a jurisdiction and obtain local surrogacy advice, seek a preliminary clinical eligibility opinion, verify donor provenance and regulatory acceptance, complete counselling and independent advice, obtain any pre-treatment approval and specific consents, and only then schedule ART procedures. If a provider declines treatment, request a written explanation identifying law, ethical standard or medical judgment. Statutory review rights depend on the decision-maker and jurisdiction; a second clinical opinion cannot override a binding ban. Avoid irreversible shipment, embryo transfer or payment before the relevant approvals and consents exist.

Decision examples and next step

Example one: a Victorian candidate who has never had a live birth cannot simply substitute a favourable health assessment for the clinic eligibility condition; the legal route must be reviewed before proceeding. Example two: a WA recipient with donor sperm purchased overseas cannot rely on the bank’s screening certificate alone; the receiving provider must check traceability, donor information, consent, limits and import compliance. Conversely, a clinic’s preference about a surrogate’s ideal age does not necessarily prove a statutory maximum age. The answer changes with the jurisdiction, treatment route, participant history and origin of the gametes.

Practical conclusion: ask two separate questions in writing: “Is this arrangement and gamete use legally permitted here?” and “Will this clinic medically and ethically accept this case?” An affirmative answer to only one is insufficient. Local counsel and the treating ART provider should verify current consolidated law, operative commencement provisions, records and the proposed treatment plan before action.

Official sources and legislation

  1. NHMRC, Ethical guidelines on the use of ART, 2017 (updated 2023)
  2. Australian Government, Components of domestic surrogacy
  3. NHMRC, ART guideline overview
  4. VARTA, Surrogacy explained
  5. WA Health, Surrogacy
  6. WA Health, new ART and surrogacy legislation
  7. WA Health, Use of gametes and embryos
  8. NSW Health, ART provider responsibilities
  9. NSW Health, Surrogacy
  10. Queensland Health, ART legislation
  11. NSW Health, NSW exemption to ART donor limit
  12. Victorian Department of Health, Guidance note: applications for approval of a surrogacy arrangement
  13. Queensland Legislation, Surrogacy Act 2010 (official consolidated text current as at 24 June 2024)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards